ALR-20083-91057
1 vaccination
1 coded response
12 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis, Pyrexia — Feeling: Good · FeverFree text: Mild fever/sweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-18
- 2021-04-23
- 2021-05-07
- 2021-10-10
- 2022-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Mild fever/sweating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release